ArticleBlood advances2022

Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomas.

Megan Fleming et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.